Drugs / ACT-1 PEPTIDE
ACT-1 PEPTIDE
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT05031806 | Sep → Dec 2021 | dry eye syndrome | Xequel Bio, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT02652572 | Sep 2015 → Dec 2017 | ulcer of lower limbs | Xequel Bio, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT02652754 | Sep 2015 → Dec 2017 | ulcer of lower limbs | Xequel Bio, Inc. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT04684121 | Aug 2022 → Aug 2024 | — | Xequel Bio, Inc. | Withdrawn | No outcome recorded Stop: Business |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT04331080 | Jul 2020 → May 2022 | hypertrophy of breast | Xequel Bio, Inc. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02667327 Comparator | Nov 2018 → May 2020 | ulcer of lower limbs | Xequel Bio, Inc. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACT-1 PEPTIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297964 ↗ |
| Known as | aCT1 | “The objective of this study is to ascertain the systemic exposure of the active ingredient in Granexin® gel (aCT1 peptide) after topical application to diabetic foot ulcers...” NCT02652754 ↗3“Granexin gel contains active pharmaceutical ingredient, aCT1 peptide, for topical application to diabetic foot ulcers once a week for up to 12 weeks or until wound closure,...” NCT02667327 ↗ “active ingredient in Granexin® gel (aCT1 peptide)” NCT02652572 ↗ |
| Known as | Acti peptide | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297964 ↗ |
| Known as | Granexin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04684121 ↗ |
| Known as | Granexin peptide | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297964 ↗ |
| Known as | Peptide 328967 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297964 ↗ |
| Modality | Peptide | “aCT1 peptide” NCT02652572 ↗ |
| Route | Topical | “after topical application to diabetic foot ulcers” NCT02652754 ↗ |